Eli Lilly Corp. buy Guggenheim
Start price
20.06.25
/
50%
€662.90
Target price
20.06.26
€813.01
Performance (%)
45.32%
End price
21.06.26
€963.30
Summary
This prediction ended on 21.06.26 with a price of €963.30. With a performance of 45.32% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 4.154% | 4.154% | 53.974% |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Eli Lilly Corp.
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
54.93%
12.07.26
12.07.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.40
14.04.25
14.04.25
€814.97
14.04.26
14.04.26
19.47%
15.04.26
15.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25